Federation des caisses Desjardins du Quebec’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-792
Closed -$91.6K 2497
2023
Q3
$91.6K Hold
792
﹤0.01% 1152
2023
Q2
$81.5K Sell
792
-382
-33% -$40.3K ﹤0.01% 1208
2023
Q1
$128K Buy
1,174
+542
+86% +$59.9K ﹤0.01% 1088
2022
Q4
$71.9K Sell
632
-1,728
-73% -$144K ﹤0.01% 1355
2022
Q3
$146K Sell
2,360
-239
-9% -$16.7K ﹤0.01% 1188
2022
Q2
$207K Buy
2,599
+1,148
+79% +$109K ﹤0.01% 1105
2022
Q1
$153K Buy
1,451
+212
+17% +$20.7K ﹤0.01% 1225
2021
Q4
$134K Buy
1,239
+50
+4% +$5.45K ﹤0.01% 1297
2021
Q3
$130K Sell
1,189
-1,146
-49% -$119K ﹤0.01% 1315
2021
Q2
$218K Sell
2,335
-915
-28% -$84.2K ﹤0.01% 1156
2021
Q1
$299K Buy
3,250
+1,040
+47% +$87.8K ﹤0.01% 993
2020
Q4
$162K Buy
+2,210
New +$164K ﹤0.01% 1118
2019
Q4
Sell
-8,764
Closed -$239K 2409
2019
Q3
$239K Buy
8,764
+4,435
+102% +$115K ﹤0.01% 987
2019
Q2
$104K Hold
4,329
﹤0.01% 1283
2019
Q1
$114K Buy
+4,329
New +$103K ﹤0.01% 1124
2017
Q4
Sell
-700
Closed -$8.88K 2213
2017
Q3
$8.88K Buy
+700
New +$8.9K ﹤0.01% 1704
2017
Q2
Sell
-90,580
Closed -$1.34M 2249
2017
Q1
$1.34M Buy
+90,580
New +$1.47M 0.03% 497

Other funds holding HZNP

Federation des caisses Desjardins du Quebec's HZNP Position: Q4 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 792 shares — an estimated $91.6K sold.

Federation des caisses Desjardins du Quebec first reported a position in HZNP in Q1 2017 and held it in 17 quarters. The position peaked at $1.34M in Q1 2017. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Federation des caisses Desjardins du Quebec reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 792 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $91.6K.
  • Federation des caisses Desjardins du Quebec first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2017 and held it in 17 quarters.
  • Federation des caisses Desjardins du Quebec's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.34M in Q1 2017.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2023, filed 15 Aug 2024.